Asia Pharma Expo completed 15 years successfully

ape-2015With APE 2015, the ASIA PHARMA EXPO series completed 12 highly successful years as a catalyst for the growth of the South Asian pharmaceutical industry.

492 Exhibiting Companies from 27 Countries, 8354 Footfalls.

From 8th to 10th January 2015 Asia Pharma Expo 2015 was held at the Bangabandhu International Conference Centre in Dhaka, Bangladesh. As South Asia’s largest pharmaceutical Manufacturing Expo, the total number of visitors expanded notably compared to that of the previous year. Asia Pharma Expo 2015 had a grand beginning witnessed by top management persons of major pharma manufacturing companies in Bangladesh. The Exhibition was inaugurated by Mr. Tofail Ahmed, MP, Hon’ble Minister of Commerce, Govt. of the People’s Republic of Bangladesh. The Minister appreciated the efforts of Bangladesh Aushad Shilpa Samity and the joint organizers; GPE EXPO PVT. LTD. for their efforts towards the establishment of a pharmaceutical manufacturing hub in Bangladesh capitalizing on the vast stride made by the Indian pharmaceutical industry in meeting the quality drug requirements worldwide at affordable prices.

Asia Pharma Expo 2015, a vital business molecule has been contributing to the growth and innovation of the Asian pharma markets in general and Bangladesh pharmaceutical industry in specific for many years, generating new business opportunities for exhibitors and visitors. Bangladesh is one of the fastest-growing economies in the world and the pharmaceutical segment has always been a top priority for the nation. There are more than 300 pharmaceutical national & multinational units operating in the country producing 97% of the local demand for drugs. With an annual double-digit growth rate, the pharmaceutical industry in Bangladesh is heading towards complete self-sufficiency in meeting local demand. There is a surety of steady growth in investments and sustained future development in the pharmaceutical industry in Bangladesh. In Bangladesh, the pharmaceutical sector is one of the fastest-growing sectors. In 2008 the total size of the pharma market in Bangladesh was estimated to be USD 700 million and is growing at a steady rate. The pharmaceutical sector is the second-highest contributor to the national exchequer and the largest white-collar labor-intensive employment sector of the country. There are 245 registered pharmaceutical manufacturing companies in Bangladesh.

Today, the Bangladesh pharmaceutical industry successfully exports APIs and a wide range of products covering all major therapeutic classes and dosage forms to more than 94 countries. Besides regular forms like tablets, capsules, and syrups, Bangladesh is also exporting high-tech specialized products like HFA Inhalers, CFC Inhalers, Suppositories, Nasal Sprays, Injectables, and IV Infusions. These products have been well accepted by medical practitioners, chemists, patients, and regulatory bodies of all importing nations. Also, the packaging and the presentation of the products in Bangladesh are comparable to any international standards.

The future of pharmaceutical exports from Bangladesh is bright. After the inclusion of the Doha declaration in the WTO/TRIPS Agreement, each and every country belonging to the LDC Category has the option not to opt for pharmaceutical product patent until 2016, which means they can now legally reverse engineer patented products and sell in their markets as well as an export to other LDCs. This creates huge export opportunities for Bangladesh, because, among all the 50 LDCs, Bangladesh is the only country that has a strong base for pharma manufacturing. Besides direct export operations, there is also a huge opportunity for Bangladeshi companies to go for contract manufacturing and compulsory licensing. The good news is, the leading pharmaceutical exporters of Bangladesh have already started availing these opportunities.

Also, the South Asia region offers several advantages. It is one of the fastest-growing pharma economies of the world and also the rapid growth rate to meet the demand & supply statistics of India, Bangladesh, Nepal, Pakistan, Bhutan, Myanmar, Thailand, and Indonesia has attracted global attention. The overall growth rate of the South Asian pharma industry is 14% with more than 24,000 formulators. With the highest exports of formulation, Bangladesh offers all the advantages of its strategic location in the South Asian pharma region.

Asia Pharma Expo 2015 was beneficial to all participants from local business associates to international machinery manufacturers and even API/Bulk Active manufacturers got benefits from participation in the exhibition. The confidence grows and reflects every year in the Asia Pharma Expo series. There were 492 exhibiting companies from 27 countries along with 8,700 Sq. Mt. of floor space and 8,354 trade professionals visited the show. Such active participation makes this exhibition a rewarding and result-oriented experience.

The exhibitor’s profile is also impressive and includes a COMPLETE spectrum comprising Pharma Processing & Packaging Machinery & Materials, API, Bulk Drugs, Formulations, Additives, Intermediates, Analytical & Biotech Lab Instruments/Glassware/Lab. Reagents – Chemicals, Lab-Consumables, Environment Control Equipment & Services, Utility Products & Services, Plant Maintenance Engineering, R&D, Biotechnology, CROs, Healthcare & Surgical Products & Consumables, Contractors – Turnkey, Trade Associations/Trade Publications, Formulations and Contract Manufacturing.

The fabulous response of the show, year after year has made Asia Pharma Expo 2015 a grand event for all the pharma professionals. For more information regarding Asia Pharma Expo 2015 call +917940008233/53, mail: mail@AsiaPharma.org, or visit the website www.AsiaPharma.org.

Check Also

Novo Nordisk raises awareness about diabetes

(Saykot Murtaza): Novo Nordisk, a Danish multinational pharmaceutical company, will observe World Health Day on …

Leave a Reply

Your email address will not be published. Required fields are marked *